EntrepreneurialCheck
Kensuke Numakura estimated net worth profile

Kensuke Numakura net worth

Kensuke Numakura Net Worth 2026 (Estimated) · Founder at Genomelink · YC S21
est. wealth $6.67M

Quick answer

Kensuke Numakura's estimated net worth is $6.67M (range $4.67M – $10.0M) as of 2026. Kensuke Numakura is Founder at Genomelink. Genomelink valuation.

Kensuke Numakura is Founder at Genomelink (YC S21). Independent Entrepreneurial Check model estimate from public YC data.

At a glance

NameKensuke Numakura
RoleFounder
CompanyGenomelink
YC batchS21
Est. company val$20.0M
Assumed ownership33.3%
Est. paper wealth / net worth$6.67M
$4.67M – $10.0M
  • Company status: Active
  • Education: University of California, Berkeley
  • Region: Japan
  • Industries: Healthcare, Consumer Health and Wellness
  • Team size: 15
  • Website: https://genomelink.io/

Who is Kensuke Numakura?

Kensuke Numakura is a founder at Genomelink, a company that focuses on personalized genomics.

Highlights:

  • University of California, Berkeley
  • J.P. Morgan
  • Y Combinator S21

About Genomelink

Genomelink is a DNA App Store. If you’ve taken a DNA test from Ancestry or 23andMe, you can upload your data to Genomelink to unlock a wide range of DNA apps: a 2,000+ region ancestry breakdown, insights from 400+ ancient DNA samples, analysis of 350+ genetic traits, unique DNA matches, and more.

Explore our latest genealogy app, YourRoots (https://yourroots.com/), which transforms your family tree into an...

FAQ: Kensuke Numakura net worth and Genomelink valuation

What is Kensuke Numakura's net worth?

Kensuke Numakura's estimated net worth is $6.67M (range $4.67M – $10.0M) as of 2026. Kensuke Numakura is Founder at Genomelink. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.

What is Genomelink valuation?

Genomelink's estimated valuation on Entrepreneurial Check is $20.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.

What is Kensuke Numakura's role?

Kensuke Numakura is Founder at Genomelink, a Y Combinator-backed startup (batch S21).